Company Information

CIN
Status
Date of Incorporation
16 June 2015
State / ROC
Bangalore / ROC Bangalore
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
962,320,900
Authorised Capital
962,500,000

Directors

Hemanth Kumar Bothra
Hemanth Kumar Bothra
Director/Designated Partner
almost 3 years ago
Chandanmal Pukhraj Bothra
Chandanmal Pukhraj Bothra
Director/Designated Partner
over 6 years ago
Dasari Ramesh
Dasari Ramesh
Company Secretary
over 8 years ago
Leela Kanwar
Leela Kanwar
Director/Designated Partner
over 10 years ago

Past Directors

Chillale Govindaraj
Chillale Govindaraj
Director
about 9 years ago

Patents

Herbal Gel Composition And Its Process Of Preparation

ABSTRACT HERBAL GEL COMPOSITION AND ITS PROCESS OF PREPARATION The present invention relates to topical herbal composition comprising natural herbal extracts as active ingredients and pharmaceutically acceptable excipients or carriers. The present invention also relates to topical herbal gel composition comprising...

Pharmaceutical Composition Of Extended Release Oral Suspension And Process For Preparation Thereof

The present invention relates to extended-release suspension composition. The present invention specifically relates to extended-release suspension composition comprising active ingredient and pharmaceutically acceptable excipients, wherein said composition is in the form of powder for suspension or a ready to use s...

Novel Processes For The Preparation Of Rapid Melt Granules

The present invention relates to Rapid melt granules prepared by encapsulation and complexation processes. The present invention specifically relates to Rapid melt granules prepared by novel process of particulate coating comprising the steps of encapsulation of active ingredient with encapsulation polymer and / or ...

Novel Composition For The Treatment Of Viral Infections

The present invention relates to the combination of primary active agent and a mucolytic agent as an adjuvant for the treatment of Viral infections. The present invention relates to the combination of primary active agent and a mucolytic agent as an adjuvant specifically for the treatment of COVID-19. The present in...

Pharmaceutical Composition Of Extended Release Oral Suspension And Process For Preparation Thereof

ABSTRACT PHARMACEUTICAL COMPOSITION OF EXTENDED-RELEASE ORAL SUSPENSION AND PROCESS FOR PREPARATION THEREOF The present invention relates to extended-release suspension composition. The present invention specifically relates to extended-release suspension composition comprising active ingredients and pharmaceuticall...

Novel Arthritis Emulgel Composition And Its Preparation Process

The present invention relates to the novel topical composition of arthritis emulgel. The present invention specifically relates to novel topical composition of arthritis emulgel comprising combination of active ingredients and pharmaceutically acceptable excipients. The present invention more specifically relates to...

Extended Release Multiple Unit Pellet System Composition And Its Process For The Preparation

The present invention relates to the novel extended release multiple unit pellet system composition and process for the preparation. The present invention specifically relates to novel extended release multiple unit pellet system composition comprising active pharmaceutical ingredient and pharmaceutically acceptable...

Taste Masked Granules Of Caffeine And Its Preparation Process

ABSTRACT TASTE MASKED GRANULE COMPOSITION OF CAFFEINE AND ITS PROCESS OF PREPARATION The present invention relates to a taste masked granule composition of Caffeine. The present invention also relates to a taste masked granule composition comprising Caffeine and pharmaceutically acceptable excipients selected fr...

Novel Processes For The Preparation Of Rapid Melt Granules

ABSTRACT NOVEL PROCESSES FOR THE PREPARATION OF RAPID MELT GRANULES The present invention relates to Rapid melt granules prepared by encapsulation and complexation processes. The present invention specifically relates to Rapid melt granules prepared by novel process of particulate coating comprising the steps of e...

Registered Trademarks

Oramelt Logo Lyrus Life Sciences

[Class : 42] Design And Development Of Medical Technology; Development Of New Technology In The Field Of Quick Mouth Dissolving Technology Used In The Manufacture Of Pharmaceutical Formulations; Research And Development Of Technology In The Field Of Quick Mouth Dissolving Technology Used In The Manufacture Of Pharmaceutical Formulations, Mouth Melting Crystals / Granules Tha...

Kancetamol Lyrus Life Sciences

[Class : 5] Pharmaceutical Products; Pharmaceutical Substances And Preparations.

Lymerus Lyrus Life Sciences

[Class : 5] Pharmaceutical Products; Pharmaceutical Substances And Preparations.
View +19 more Brands for Lyrus Life Sciences Private Limited.

Charges

43 Crore
04 September 2018
Canara Bank
43 Crore
04 September 2018
Canara Bank
0
04 September 2018
Canara Bank
0